Corline intensifierar kommersiell satsning i USA

RegulatoryapprovedGlobe® Pulsed Field SystemPositive

AI Analysis

Summary

Corline Biomedical AB is intensifying its US commercial strategy following FDA approval of Kardium's Globe® Pulsed Field System, aiming to recruit 3-5 major customers for its CHS technology by 2029.

Outcome Details

FDA approval of Kardium's Globe® Pulsed Field System

Importance:5/10

Sentiment:

0.70

FDA approvalcommercial expansionUS marketmedical devicebusiness development

Read the original article

Published by GlobeNewswire Pharma on August 26, 2026 6:11 AM

Read Original